MTOR and cancer: The function of various types of immune components, including T cells, B cells, macrophages, and DCs can be altered via the modulation of mTOR signaling in the tumor microenvironment, suggesting a therapeutic benefit of cancer immunotherapy via targeting the mTOR signaling pathway [28,29].